$25.36
-0.200 (-0.783%)
At Close: Jun 03, 2026
TrumpRx lists many medicines at prices higher than paid in UK
02:23pm, Wednesday, 18'th Mar 2026
U.S. President Donald Trump pledged to make prescription drugs cheaper for Americans than anywhere in the world, but his TrumpRx.gov website is not delivering across the board lower prices than those
PFE's Atirmociclib 2L Breast Cancer Study Hits Goal, Aid Pipeline Push
12:27pm, Wednesday, 18'th Mar 2026
Pfizer's phase II study evaluating CDK4 inhibitor, atirmociclib, in 2L metastatic breast cancer meets primary endpoint. Supports oncology pipeline progress.
Pfizer: I'm Still Expecting A Massive Rebound
09:00am, Wednesday, 18'th Mar 2026
Pfizer Inc.'s non-COVID operational revenue grew 9% in Q4, successfully offsetting the ongoing decline in pandemic-related sales and signaling a structural shift toward long-term growth. The Seagen in
The Best Healthcare Stocks to Buy With $50 Right Now
08:30am, Wednesday, 18'th Mar 2026
Pfizer and Novo Nordisk look cheap in more ways than one. Pipeline progress could help improve their financial results.
20 Years on Wall Street Taught Me: Big Dividend Healthcare Stocks Never Go Out of Style
07:19am, Wednesday, 18'th Mar 2026
After a career spanning two decades at Bear Stearns, Lehman Brothers, and Morgan Stanley, I gained an institutional perspective on dividend stock investing.
Captrust Financial Advisors Cuts Stake in Pfizer Inc. $PFE
05:00am, Wednesday, 18'th Mar 2026
Captrust Financial Advisors lowered its holdings in shares of Pfizer Inc. (NYSE: PFE) by 0.9% during the undefined quarter, according to the company in its most recent filing with the SEC. The fund ow
Mpox Is on the Rise. 3 Vaccine Stocks Worth a Second Look.
12:49pm, Tuesday, 17'th Mar 2026
The first severe case of the virus has been detected in New York.
Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know
10:01am, Tuesday, 17'th Mar 2026
Recently, Zacks.com users have been paying close attention to Pfizer (PFE). This makes it worthwhile to examine what the stock has in store.
Pfizer says experimental breast cancer drug cuts risk of disease worsening in mid-stage trial
07:49am, Tuesday, 17'th Mar 2026
Pfizer said on Tuesday its experimental combination reduced the risk of disease progression or death by 40% in patients with breast cancer.
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced positive topline results from the randomized Phase 2 FOURLIGHT-1 study evaluating atirmociclib in combination with fulvestrant, versu
IP Group returns to growth as Pfizer deal drives NAV rise
03:51am, Tuesday, 17'th Mar 2026
The university spinout investor posted a 13% increase in net asset value per share after Pfizer's acquisition of obesity drug developer Metsera IP Group PLC (LSE:IPO), the London-listed investor in un
Should You Avoid Pfizer? Here's the Key Risk to Watch
01:15am, Tuesday, 17'th Mar 2026
Pfizer's revenue reached $100 billion a few years ago, driven by its dominance in coronavirus treatments and prevention. In recent times, it's faced a drop in that demand and losses of exclusivity con
PFE vs BMY: Which Large Oncology Drugmaker Is a Better Pick Now?
03:45pm, Monday, 16'th Mar 2026
Pfizer and Bristol Myers are racing to strengthen oncology portfolios through deals, new drugs and pipelines ??? investors are weighing which stock stands out.
3 Monster Dividend Stocks to Hold for the Next 10 Years
05:43am, Monday, 16'th Mar 2026
Enterprise Products Partners is poised to benefit from increased demand for natural gas and natural gas liquids. Pfizer should be able to successfully navigate its looming patent cliff.
Ameriprise Financial Inc. Increases Holdings in Pfizer Inc. $PFE
03:26am, Monday, 16'th Mar 2026
Ameriprise Financial Inc. grew its stake in Pfizer Inc. (NYSE: PFE) by 48.2% during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The inst
Sign In
Buy PFE